A Multifactorial Likelihood Model for MMR Gene Variant Classification Incorporating Probabilities Based on Sequence Bioinformatics and Tumor Characteristics: A Report from the Colon Cancer Family Registry
暂无分享,去创建一个
Steven Gallinger | John L Hopper | Sean V Tavtigian | Bryony A Thompson | Robert W Haile | J. Hopper | S. Thibodeau | A. Spurdle | S. Tavtigian | S. Gallinger | P. Newcomb | M. Jenkins | Joanne P Young | N. Lindor | C. Paterson | B. Thompson | D. Buchanan | M. Clendenning | R. Haile | D. Goldgar | M. Parsons | Amanda B Spurdle | Michael T Parsons | David E Goldgar | Stephen N Thibodeau | Mark A Jenkins | Polly A Newcomb | Noralane M Lindor | Rhiannon Walters | Mark Clendenning | L. LeMarchand | Daniel D Buchanan | Loic Lemarchand | Carol Paterson | Sven Arnold | Walsh Michael D | S. Arnold | Rhiannon J. Walters | Walsh Michael D | M. Jenkins
[1] Predrag Radivojac,et al. Calibration of Multiple In Silico Tools for Predicting Pathogenicity of Mismatch Repair Gene Missense Substitutions , 2013, Human mutation.
[2] F. Couch,et al. The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumors. , 2012, Journal of Molecular Diagnostics.
[3] A. Spurdle,et al. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification , 2012, Journal of Medical Genetics.
[4] F. Couch,et al. Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary , 2011, Human mutation.
[5] J. Fléjou,et al. Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications , 2011, Cellular Oncology.
[6] A. Viel,et al. Integrated analysis of unclassified variants in mismatch repair genes , 2011, Genetics in Medicine.
[7] Á. Carracedo,et al. Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome , 2011, BMC Medical Genetics.
[8] F. Hogervorst,et al. A novel pathogenic MLH1 missense mutation, c.112A > C, p.Asn38His, in six families with Lynch syndrome , 2010, Hereditary cancer in clinical practice.
[9] Aung Ko Win,et al. Risk Factors for Colorectal Cancer in Patients with Multiple Serrated Polyps: A Cross-Sectional Case Series from Genetics Clinics , 2010, PloS one.
[10] A. Spurdle. Clinical relevance of rare germline sequence variants in cancer genes: evolution and application of classification models. , 2010, Current opinion in genetics & development.
[11] E. Stoffel,et al. Effect of smoking on urothelial cancer risk in individuals with Lynch syndrome , 2010, Hereditary Cancer in Clinical Practice.
[12] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[13] Finlay Macrae,et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers. , 2010, Journal of the National Cancer Institute.
[14] P. Hutter,et al. Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation , 2010, Familial Cancer.
[15] H T Lynch,et al. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications , 2009, Clinical genetics.
[16] John L Hopper,et al. Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics , 2009, Human mutation.
[17] C. Béroud,et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.
[18] M. Woods,et al. Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis , 2009, Familial Cancer.
[19] A. Spurdle,et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results , 2008, Human mutation.
[20] F. Couch,et al. Prediction and assessment of splicing alterations: implications for clinical testing , 2008, Human mutation.
[21] S. Tavtigian,et al. In silico analysis of missense substitutions using sequence‐alignment based methods , 2008, Human mutation.
[22] F. Couch,et al. Assessment of functional effects of unclassified genetic variants , 2008, Human mutation.
[23] N. de Wind,et al. Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance , 2008, Human mutation.
[24] Douglas F Easton,et al. Genetic evidence and integration of various data sources for classifying uncertain variants into a single model , 2008, Human mutation.
[25] J. Lindebjerg,et al. Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency , 2008, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[26] H. Campbell,et al. Classification of ambiguous mutations in DNA mismatch repair genes identified in a population‐based study of colorectal cancer , 2008, Human mutation.
[27] B. Bellosillo,et al. A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[28] B. Bapat,et al. The MLH1 variants p.Arg265Cys and p.Lys618Ala affect protein stability while p.Leu749Gln affects heterodimer formation , 2008, Human mutation.
[29] O. Csuka,et al. Two germline alterations in mismatch repair genes found in a HNPCC patient with poor family history , 2006, Pathology & Oncology Research.
[30] Fergus J Couch,et al. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. , 2007, American journal of human genetics.
[31] John D Potter,et al. Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.
[32] Michael O Woods,et al. A new variant database for mismatch repair genes associated with Lynch syndrome , 2007, Human mutation.
[33] M. Trivett,et al. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer , 2007, Familial Cancer.
[34] K. Kinzler,et al. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. , 2007, Journal of the National Cancer Institute.
[35] P. Radice,et al. A human cell-based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene. , 2006, Cancer research.
[36] A. Viel,et al. Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features , 2006, European Journal of Human Genetics.
[37] M. Genuardi,et al. The use of microsatellite instability, immunohistochemistry and other variables in determining the clinical significance of MLH1 and MSH2 unclassified variants in Lynch syndrome. , 2006, Cancer biomarkers : section A of Disease markers.
[38] M. Kloor,et al. Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer , 2006, International journal of cancer.
[39] P. Propping,et al. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining , 2005, The Journal of pathology.
[40] D. Baralle,et al. Splicing in action: assessing disease causing sequence changes , 2005, Journal of Medical Genetics.
[41] J. Trojan,et al. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite‐unstable tumors , 2005, Cancer.
[42] A. Sidow,et al. Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity. , 2005, Genome research.
[43] Hiroyuki Yamamoto,et al. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes , 2005, Oncogene.
[44] H C van Houwelingen,et al. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment , 2005, Journal of Medical Genetics.
[45] J. Hopper,et al. Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[46] J. Perkel,et al. The yeast two-hybrid assay , 2005 .
[47] Prathap Bandipalliam. Syndrome of Early Onset Colon Cancers, Hematologic Malignancies & Features of Neurofibromatosis in HNPCC Families with Homozygous Mismatch Repair Gene Mutations , 2005, Familial Cancer.
[48] P. Peltomäki,et al. Mutations Associated with HNPCC Predisposition — Update of ICG-HNPCC/INSiGHT Mutation Database , 2004, Disease markers.
[49] F. Couch,et al. Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. , 2004, American journal of human genetics.
[50] L. Aaltonen,et al. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing , 2004, Journal of Medical Genetics.
[51] R. Weksberg,et al. Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. , 2004, Gastroenterology.
[52] G. Deng,et al. BRAF Mutation Is Frequently Present in Sporadic Colorectal Cancer with Methylated hMLH1, But Not in Hereditary Nonpolyposis Colorectal Cancer , 2004, Clinical Cancer Research.
[53] B. Leggett,et al. Promoter Hypermethylation Frequency and BRAF Mutations Distinguish Hereditary Non-Polyposis Colon Cancer from Sporadic MSI-H Colon Cancer , 2004, Familial Cancer.
[54] D. Schaid,et al. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. , 2003, Cancer research.
[55] Douglas F Easton,et al. A full-likelihood method for the evaluation of causality of sequence variants from family data. , 2003, American journal of human genetics.
[56] Hideyuki Suzuki,et al. A yeast two-hybrid assay provides a simple way to evaluate the vast majority of hMLH1 germ-line mutations. , 2003, Cancer research.
[57] Christopher B. Burge,et al. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.
[58] P. Gregersen,et al. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. , 2002, American journal of human genetics.
[59] K. Kinzler,et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status , 2002, Nature.
[60] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[61] M. Benito,et al. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain , 2002, International journal of cancer.
[62] Daniel J Sargent,et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[63] H. Nagai,et al. Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability. , 2001, Gastroenterology.
[64] D. Aust,et al. Sixteen rare sequence variants of the hMLH1 and hMSH2 genes found in a cohort of 254 suspected HNPCC (hereditary non-polyposis colorectal cancer) patients: mutations or polymorphisms? , 2001, European journal of medical research.
[65] V. Weinberg,et al. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. , 2001, Gastroenterology.
[66] Anastassis Perrakis,et al. The crystal structure of DNA mismatch repair protein MutS binding to a G·T mismatch , 2000, Nature.
[67] Wei Yang,et al. Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA , 2000, Nature.
[68] L. Aaltonen,et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[69] W. Foulkes,et al. A missense mutation in both hMSH2 andAPC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening , 1999, Journal of medical genetics.
[70] J. Saurin,et al. Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer , 1999, Human Genetics.
[71] J. Herman,et al. CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[72] R. Fishel,et al. The Interaction of the Human MutL Homologues in Hereditary Nonpolyposis Colon Cancer* , 1999, The Journal of Biological Chemistry.
[73] A. Viel,et al. Lack of PMS2 gene-truncating mutations in patients with hereditary colorectal cancer. , 1998, International journal of oncology.
[74] S N Thibodeau,et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. , 1998, Cancer research.
[75] J. Herman,et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[76] L. Aaltonen,et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. , 1998, The New England journal of medicine.
[77] A. Viel,et al. MLH1 and MSH2 constitutinal mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer , 1998, International journal of cancer.
[78] David Haussler,et al. Improved splice site detection in Genie , 1997, RECOMB '97.
[79] B. Sugden,et al. Clonal transformation of adult human leukocytes by Epstein-Barr virus , 1977, Journal of virology.